All News
EULAR 2023: Featured Industry Presentations
EULAR 2023 opens tomorrow, Wednesday May 31st, with hundreds of novel presentations and pivotal clinical trials, many being featured industry sponsored clinical trials and research on their novel agents. Below is a collection of the featured abstracts, and presentation times from EULAR
Read Article
Leiden arthritis clinic:
1000+ pts w/ RA & high BMI associated w/ < MRI-detected osteitis at dis onset but NOT synovitis
RA w/ overweight/obesity 25% < MRI-detected erosive progression at 2 yrs
More marked in ACPA+ pts
Is leptin the missing link? 🤓
OP0039 #EULAR23 @Rheumnow https://t.co/RRSV9VlRtn
Aurelie Najm AurelieRheumo ( View Tweet)
Biosimilar vs originator: as switches loom in the US, once again it’s really hard to say we see any differences in drug survival for our RA patients
These data from forced switching in BC, Canada are just like the others - biosimilars are business as usual. POS0567 #EULAR2023 https://t.co/Ebl1hTM4qE
David Liew drdavidliew ( View Tweet)
Ongoing work to #classify #inflammatory #arthritis in Pts using #check #point #inhibitors. A 1st step to study the etiology of immune changes from these life prolonging medications #EULAR2023 @RheumNow https://t.co/Bv1q8IphqF
Janet Pope Janetbirdope ( View Tweet)
Different B cell depleting agents! #Eular2023 https://t.co/GsmdIHgOcl
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Can #machine #learning replace #rheumatologists? OP0190 #EULAR23 #Machine learning can help determine who will develop #rheumatoidarthritis in Pts with #arthralgia but the real study could be ask #clinician the #probability of RA and do #AI and see comparative accuracy @RheumNow
Janet Pope Janetbirdope ( View Tweet)
There are lots of reasons why axSpA treatments fail for patients. And as rheumatologists, we can’t just prescribe and walk away - we need to address each in turn, for our patients’ sake #EULAR2023 @RheumNow https://t.co/hzo57BaEXw
David Liew drdavidliew ( View Tweet)
#Precision medicine in #SLE #Interferon is not a good predictor of remission as it takes a LONG time to normalize in #Lupus @RheumNow @eular_org #EULAR2023 abst#OP https://t.co/JkWnk94bHu
Janet Pope Janetbirdope ( View Tweet)
RheumNow’s expanded coverage of the #EULAR2023 Annual meeting is sponsored in part by Bristol Myers Squibb. All content is chosen by RheumNow and its Faculty.
Dr. John Cush RheumNow ( View Tweet)
EULAR opens their meeting as a leader in #Rheumatology education and >5800 abstracts. A warm welcome for #EULAR2023 from the president! @RheumNow Opening ceremony. Impressive! https://t.co/RLQLQGOA8K
Janet Pope Janetbirdope ( View Tweet)
When does RA get complicated?
Many things can burden our patients, making their RA difficult to treat #EULAR2023 @RheumNow https://t.co/FM1UCNbmKr
David Liew drdavidliew ( View Tweet)
#EULAR2023 https://t.co/KwFnvzdNzz
Christian Ammitzbøll RheumTweeter ( View Tweet)
Researchers@of tomorrow. Winners of EULAR basic and epi and clinical abstract awards - young leaders! @RheumNow #EULAR2023 @eular_org https://t.co/VsV5aQpxjs
Janet Pope Janetbirdope ( View Tweet)
Delighted to be reporting for @RheumNow LIVE from Milan 🇮🇹 #EULAR2023 alongside my esteemed colleagues @drdavidliew @Janetbirdope @jeffsparks @synovialjoints @AurelieRheumo @bella_mehta 🙌🏻 Do follow us for Congress coverage 😃 https://t.co/tmD4vVWnQk
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
#EULAR2023 Please find my first article on Congress Preview of Promising New Therapies in #lupus #SLE @RheumNow
https://t.co/SFvhsP8QWO https://t.co/m5UwBGCXFB
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
A full house for the #EULAR2023 Opening session @eular_org setting the tone for an exciting few days to come!
@RheumNow https://t.co/bZSIL78mU6
Aurelie Najm AurelieRheumo ( View Tweet)
Tuesday Night Rheumatology: POD 4: Rheumatoid Arthritis: Decisive Therapeutics https://t.co/GzLE2XLe1q
Dr. John Cush RheumNow ( View Tweet)
Watch: A Family History of Ankylosing Spondylitis
https://t.co/3U7DG8P52c https://t.co/lxial62ujS
Links:
Dr. John Cush RheumNow ( View Tweet)
Watch: Evaluation of Sacroiliac Joint
RheumNow Live: Prof. Denis Poddubnyy, Charité University Hospital, Berlin
https://t.co/vH866d5sy6 https://t.co/zSMMBedyoG
Links:
Dr. John Cush RheumNow ( View Tweet)
Prevalence of PsA, Spondyloarthritis and Rheumatoid Arthritis in Norway
Recent reports have suggested a rising and unrecognized number of patients with PsA and axSpA compared to RA. This has implications on diagnosis and population care.
https://t.co/D0SvKP2MIa https://t.co/Gjh0oSZ5S2
Links:
Dr. John Cush RheumNow ( View Tweet)